|
1
|
Sun Z, Nie X, Sun S, Dong S, Yuan C, Li Y,
Xiao B, Jie D and Liu Y: Long non-coding RNA MEG3 downregulation
triggers human pulmonary artery smooth muscle cell proliferation
and migration via the p53 signaling pathway. Cell Physiol Biochem.
42:2569–2581. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stenmark KR, Fagan KA and Frid MG:
Hypoxia-induced pulmonary vascular remodeling: Cellular and
molecular mechanisms. Circ Res. 99:675–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Howell K, Preston RJ and McLoughlin P:
Chronic hypoxia causes angiogenesis in addition to remodelling in
the adult rat pulmonary circulation. J Physiol. 547:133–145. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pietra GG, Capron F, Stewart S, Leone O,
Humbert M, Robbins IM, Reid LM and Tuder RM: Pathologic assessment
of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 43
(Suppl S):25S–32S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harries LW: Long non-coding RNAs and human
disease. Biochem Soc Trans. 40:902–906. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park JY, Lee JE, Park JB, Yoo H, Lee SH
and Kim JH: Roles of long non-coding RNAs on tumorigenesis and
glioma development. Brain Tumor Res Treat. 2:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li T, Mo X, Fu L, Xiao B and Guo J:
Molecular mechanisms of long noncoding RNAs on gastric cancer.
Oncotarget. 7:8601–8612. 2016.PubMed/NCBI
|
|
8
|
Roberts R: Genetics of coronary artery
disease: An update. Methodist Debakey Cardiovasc J. 10:7–12. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pasmant E, Laurendeau I, Héron D, Vidaud
M, Vidaud D and Bièche I: Characterization of a germ-line deletion,
including the entire INK4/ARF locus, in a melanoma-neural system
tumor family: Identification of ANRIL, an antisense noncoding RNA
whose expression coclusters with ARF. Cancer Res. 67:3963–3969.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tano K and Akimitsu N: Long non-coding
RNAs in cancer progression. Front Genet. 3:2192012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schaefer AS, Bochenek G, Manke T,
Nothnagel M, Graetz C, Thien A, Jockel-Schneider Y, Harks I,
Staufenbiel I, Wijmenga C, et al: Validation of reported genetic
risk factors for periodontitis in a large-scale replication study.
J Clin Periodontol. 40:563–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Masharawi YM, Kjaer P, Bendix T, Manniche
C, May H, Mirovsky Y, Anekshtein Y, Jensen TS and Hershkovitz I:
Lumbar facet and interfacet shape variation during growth in
children from the general population: A three-year follow-up MRI
study. Spine (Phila Pa 1976). 34:408–412. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Congrains A, Kamide K, Katsuya T, Yasuda
O, Oguro R, Yamamoto K, Ohishi M and Rakugi H: CVD-associated
non-coding RNA, ANRIL, modulates expression of atherogenic pathways
in VSMC. Biochem Biophys Res Commun. 419:612–616. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou X, Han X, Wittfeldt A, Sun J, Liu C,
Wang X, Gan LM, Cao H and Liang Z: Long non-coding RNA ANRIL
regulates inflammatory responses as a novel component of NF-κB
pathway. RNA Biol. 13:98–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu X, Li T, Liu X, Yu H, Hao Z, Chen Y,
Zhang C, Liu Y, Li Q, Mao M and Zhu D: Modulation of pulmonary
vascular remodeling in hypoxia: Role of 15-LOX-2/15-HETE-MAPKs
Pathway. Cell Physiol Biochem. 35:2079–2097. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aguilo F, Di Cecilia S and Walsh MJ: Long
Non-coding RNA ANRIL and Polycomb in human cancers and
cardiovascular disease. Curr Top Microbiol Immunol. 394:29–39.
2016.PubMed/NCBI
|
|
19
|
Zhang B, Wang D, Ji TF, Shi L and Yu JL:
Overexpression of lncRNA ANRIL up-regulates VEGF expression and
promotes angiogenesis of diabetes mellitus combined with cerebral
infarction by activating NF-κB signaling pathway in a rat model.
Oncotarget. 8:17347–17359. 2017.PubMed/NCBI
|
|
20
|
Zhang H, Liu Y, Yan L, Wang S, Zhang M, Ma
C, Zheng X, Chen H and Zhu D: Long noncoding RNA Hoxaas3
contributes to hypoxia-induced pulmonary artery smooth muscle cell
proliferation. Cardiovasc Res. 115:647–657. 2018. View Article : Google Scholar
|
|
21
|
Qiu JJ, Wang Y, Liu YL, Zhang Y, Ding JX
and Hua KQ: The long non-coding RNA ANRIL promotes proliferation
and cell cycle progression and inhibits apoptosis and senescence in
epithelial ovarian cancer. Oncotarget. 7:32478–32492. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen S, Zhang JQ, Chen JZ, Chen HX, Qiu
FN, Yan ML, Chen YL, Peng CH, Tian YF and Wang YD: The over
expression of long non-coding RNA ANRIL promotes
epithelial-mesenchymal transition by activating the ATM-E2F1
signaling pathway in pancreatic cancer: An in vivo and in vitro
study. Int J Biol Macromol. 102:718–728. 2017. View Article : Google Scholar : PubMed/NCBI
|
